These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2569211)

  • 1. The conformational restriction of synthetic peptides, including a malaria peptide, for use as immunogens.
    Satterthwait AC; Arrhenius T; Hagopian RA; Zavala F; Nussenzweig V; Lerner RA
    Philos Trans R Soc Lond B Biol Sci; 1989 Jun; 323(1217):565-72. PubMed ID: 2569211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational restriction of peptidyl immunogens with covalent replacements for the hydrogen bond.
    Satterthwait AC; Arrhenius T; Hagopian RA; Zavala F; Nussenzweig V; Lerner RA
    Vaccine; 1988 Apr; 6(2):99-103. PubMed ID: 3291460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The conformational restriction of synthetic vaccines for malaria.
    Satterthwait AC; Chiang LC; Arrhenius T; Cabezas E; Zavala F; Dyson HJ; Wright PE; Lerner RA
    Bull World Health Organ; 1990; 68 Suppl(Suppl):17-25. PubMed ID: 2094582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of immunogens for synthetic malaria vaccines.
    Lise D; Dubeaux C; Tello D; Mazier D; Jolivet M; Schlesinger DH; Audibert F; Chedid L
    Biochem Biophys Res Commun; 1988 May; 153(1):31-8. PubMed ID: 3288205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational preferences of synthetic peptides derived from the immunodominant site of the circumsporozoite protein of Plasmodium falciparum by 1H NMR.
    Dyson HJ; Satterthwait AC; Lerner RA; Wright PE
    Biochemistry; 1990 Aug; 29(34):7828-37. PubMed ID: 2261440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a peptide sequence of the 25 kD surface protein of Plasmodium falciparum recognized by transmission-blocking monoclonal antibodies: implications for synthetic vaccine development.
    van Amerongen A; Sauerwein RW; Beckers PJ; Meloen RH; Meuwissen JH
    Parasite Immunol; 1989 Jul; 11(4):425-8. PubMed ID: 2674864
    [No Abstract]   [Full Text] [Related]  

  • 7. The development of molecular vaccines against malaria sporozoites.
    Ballou WR; Young JF; Cryz SJ; Sadoff JC
    Adv Exp Med Biol; 1989; 251():295-313. PubMed ID: 2692428
    [No Abstract]   [Full Text] [Related]  

  • 8. Conformation and immunogenicity of engineered repeating segment of the circumsporozoite surface protein of Plasmodium falciparum.
    Armah GE; Nishikawa S; Miki S; Omata Y; Nakabayashi T; Tomita K
    Mol Biochem Parasitol; 1990 Jan; 38(1):135-40. PubMed ID: 2181302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of H-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide.
    Pessi A; Valmori D; Migliorini P; Tougne C; Bianchi E; Lambert PH; Corradin G; Del Giudice G
    Eur J Immunol; 1991 Sep; 21(9):2273-6. PubMed ID: 1889465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.
    Del Giudice G; Cooper JA; Merino J; Verdini AS; Pessi A; Togna AR; Engers HD; Corradin G; Lambert PH
    J Immunol; 1986 Nov; 137(9):2952-5. PubMed ID: 3531341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.
    Patarroyo ME; Amador R; Clavijo P; Moreno A; Guzman F; Romero P; Tascon R; Franco A; Murillo LA; Ponton G
    Nature; 1988 Mar; 332(6160):158-61. PubMed ID: 2450281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display.
    Crossey E; Frietze K; Narum DL; Peabody DS; Chackerian B
    PLoS One; 2015; 10(7):e0132560. PubMed ID: 26147502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of an engineered internal image antibody.
    Billetta R; Hollingdale MR; Zanetti M
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4713-7. PubMed ID: 1905014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.
    Rzepczyk CM; Csurhes PA; Lord R; Matile H
    J Immunol; 1990 Oct; 145(8):2691-6. PubMed ID: 2212657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel design of peptide immunogens: synthetic peptide with a reversible handle for the attachment to protein carriers.
    Vergara U; Tam JP
    Pept Res; 1989; 2(1):134-9. PubMed ID: 2520750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibodies to Plasmodium falciparum sporozoites by employing synthetic peptides.
    Del Giudice G; Biro S; Degrémont AA; Engers HD; Lambert PH; Pessi A; Tougne C; Verdini AS; Weiss N; Tanner M
    Parassitologia; 1986; 28(2-3):107-11. PubMed ID: 3332303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines for human malaria: epidemiological and immunological perspectives.
    Webster HK; Diggs CL; Ballou WR; Chulay JD
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):375-89. PubMed ID: 3064321
    [No Abstract]   [Full Text] [Related]  

  • 18. Cloned antigens from Plasmodium falciparum as malaria vaccine candidates.
    Pink JR; Caspers P; Etlinger H; Guttinger M; Matile H; Reber R; Schönfeld HJ; Sinigaglia F; Stüber D; Stürchler D
    Behring Inst Mitt; 1991 Feb; (88):142-6. PubMed ID: 2049031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary structure and immunogenicity of hybrid synthetic peptides derived from two Plasmodium falciparum pre-erythrocytic antigens.
    Londoño JA; Gras-Masse H; Dubeaux C; Tartar A; Druilhe P
    J Immunol; 1990 Sep; 145(5):1557-63. PubMed ID: 2143519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
    Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
    Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.